-
Sarepta Therapeutics – J.P. Morgan 2020 Presentation
-
Sarepta Therapeutics 2019 Corporate Presentation
-
Latest Annual Report
( FY 2018 )Latest Annual Report 1.5 MB -
R&D Day 2018 Presentation
R&D Day 2018 Presentation 12.7 MB
SEC Filings
| Filing date | Form | Description | Filing Group | View |
|---|---|---|---|---|
| 3 | Initial filing by director officer or owner of more than ten percent. |
3,4,5
|
View HTML | |
| 8-K | Report of unscheduled material events or corporate event |
Current Reports
|
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML | |
| 8-K | Report of unscheduled material events or corporate event |
Current Reports
|
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML | |
| 4 | Statement of changes in beneficial ownership of securities |
3,4,5
|
View HTML | |
| 8-K | Report of unscheduled material events or corporate event |
Current Reports
|
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML | |
| 4 | Statement of changes in beneficial ownership of securities |
3,4,5
|
View HTML | |
| 4 | Statement of changes in beneficial ownership of securities |
3,4,5
|
View HTML | |
| 4 | Statement of changes in beneficial ownership of securities |
3,4,5
|
View HTML | |
| 8-K | Report of unscheduled material events or corporate event |
Current Reports
|
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML | |
| 4 | Statement of changes in beneficial ownership of securities |
3,4,5
|
View HTML |
Displaying 1 - 10 of 1076 results
Copyright Morningstar
-
Sarepta Therapeutics – J.P. Morgan 2020 Presentation
-
Sarepta Therapeutics 2019 Corporate Presentation
-
Latest Annual Report
( FY 2018 )Latest Annual Report 1.5 MB -
R&D Day 2018 Presentation
R&D Day 2018 Presentation 12.7 MB